IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 247 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.25 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $207,334 | -8.8% | 45,568 | +41.1% | 0.00% | – |
Q2 2023 | $227,336 | +20.0% | 32,292 | +4.2% | 0.00% | -100.0% |
Q1 2023 | $189,410 | -4.4% | 31,000 | 0.0% | 0.00% | +33.3% |
Q4 2022 | $198,090 | -54.0% | 31,000 | -31.1% | 0.00% | -40.0% |
Q3 2022 | $431,000 | +62.6% | 45,000 | +87.3% | 0.01% | +66.7% |
Q2 2022 | $265,000 | -44.7% | 24,032 | -16.5% | 0.00% | -40.0% |
Q1 2022 | $479,000 | +29.8% | 28,794 | +48.5% | 0.01% | +25.0% |
Q4 2021 | $369,000 | -20.8% | 19,387 | +2.6% | 0.00% | -33.3% |
Q3 2021 | $466,000 | -22.3% | 18,892 | -18.1% | 0.01% | -25.0% |
Q2 2021 | $600,000 | +80.2% | 23,066 | +118.9% | 0.01% | +60.0% |
Q1 2021 | $333,000 | – | 10,535 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
MHR Fund Management | 19,997,103 | $90,986,819 | 11.15% |
MPM BioImpact LLC | 3,287,397 | $14,957,656 | 3.99% |
Perceptive Advisors | 11,962,938 | $54,431,367 | 1.82% |
CM Management, LLC | 200,000 | $910,000 | 0.97% |
Velan Capital Investment Management LP | 250,000 | $1,137,500 | 0.92% |
Opaleye Management Inc. | 610,000 | $2,775,500 | 0.90% |
Boxer Capital, LLC | 3,705,133 | $16,858,355 | 0.90% |
SECTORAL ASSET MANAGEMENT INC | 985,000 | $4,481,750 | 0.87% |
Parametrica Management Ltd | 95,400 | $434,070 | 0.73% |
683 Capital Management, LLC | 2,050,000 | $9,327,501 | 0.72% |